ATE469643T1 - Mit gesättigten o-heterocyclen substituierte alkansäureamide - Google Patents

Mit gesättigten o-heterocyclen substituierte alkansäureamide

Info

Publication number
ATE469643T1
ATE469643T1 AT06778437T AT06778437T ATE469643T1 AT E469643 T1 ATE469643 T1 AT E469643T1 AT 06778437 T AT06778437 T AT 06778437T AT 06778437 T AT06778437 T AT 06778437T AT E469643 T1 ATE469643 T1 AT E469643T1
Authority
AT
Austria
Prior art keywords
heterocycles
saturated
acid amides
alkanoic acid
amides substituted
Prior art date
Application number
AT06778437T
Other languages
English (en)
Inventor
Peter Herold
Robert Mah
Vincenzo Tschinke
Stefan Stutz
Aleksandar Stojanovic
Stjepan Jelakovic
Christiane Marti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE469643T1 publication Critical patent/ATE469643T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT06778437T 2005-09-17 2006-09-14 Mit gesättigten o-heterocyclen substituierte alkansäureamide ATE469643T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH15182005 2005-09-17
PCT/EP2006/066368 WO2007031557A2 (en) 2005-09-17 2006-09-14 Alcanoic acid amides substituted by saturated o-heterocycles

Publications (1)

Publication Number Publication Date
ATE469643T1 true ATE469643T1 (de) 2010-06-15

Family

ID=37847050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778437T ATE469643T1 (de) 2005-09-17 2006-09-14 Mit gesättigten o-heterocyclen substituierte alkansäureamide

Country Status (15)

Country Link
US (2) US8058307B2 (de)
EP (1) EP1937248B1 (de)
JP (1) JP2009507899A (de)
CN (1) CN101262864A (de)
AR (1) AR057816A1 (de)
AT (1) ATE469643T1 (de)
BR (1) BRPI0616219A2 (de)
CA (1) CA2622375A1 (de)
DE (1) DE602006014707D1 (de)
ES (1) ES2346081T3 (de)
IL (1) IL190060A0 (de)
PL (1) PL1937248T3 (de)
PT (1) PT1937248E (de)
TW (1) TW200804330A (de)
WO (1) WO2007031557A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080176947A1 (en) * 2005-03-11 2008-07-24 Peter Herold Heterocyclic-Substituted Alkanamides Useful as Renin Inhibitors
PT2420491E (pt) 2005-12-30 2013-10-14 Novartis Ag Compostos de piperidina 3,5-substituída como inibidores de renina
EP1958666A1 (de) * 2007-02-13 2008-08-20 Speedel Experimenta AG Heterozyklische substituierte Alkanamide als therapeutische Verbindungen
NZ582098A (en) 2007-06-25 2012-03-30 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
US8968362B2 (en) * 2010-04-08 2015-03-03 Covidien Lp Coated looped suture
CN103402971A (zh) * 2011-01-07 2013-11-20 塔加西普特公司 烟碱受体非竞争性拮抗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
AU2004293178B8 (en) * 2003-11-26 2009-01-08 Novartis Ag Organic compounds
TW200633983A (en) * 2004-12-10 2006-10-01 Speedel Experimenta Ag 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-nonanamides
US20080176947A1 (en) 2005-03-11 2008-07-24 Peter Herold Heterocyclic-Substituted Alkanamides Useful as Renin Inhibitors

Also Published As

Publication number Publication date
EP1937248B1 (de) 2010-06-02
CN101262864A (zh) 2008-09-10
JP2009507899A (ja) 2009-02-26
IL190060A0 (en) 2008-12-29
DE602006014707D1 (de) 2010-07-15
CA2622375A1 (en) 2007-03-22
WO2007031557A3 (en) 2007-05-24
US20090275651A1 (en) 2009-11-05
BRPI0616219A2 (pt) 2011-06-14
WO2007031557A2 (en) 2007-03-22
US20110144197A1 (en) 2011-06-16
US8058307B2 (en) 2011-11-15
AR057816A1 (es) 2007-12-19
EP1937248A2 (de) 2008-07-02
ES2346081T3 (es) 2010-10-08
PT1937248E (pt) 2010-07-06
PL1937248T3 (pl) 2010-11-30
TW200804330A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
FR22C1054I2 (fr) Amides peptidiques synthetiques
LTC1912503I2 (lt) Fungicidiniai mišiniai, turintys 1-metilpirazol-4-ilo karboksirūgšties anilidus
ATE408608T1 (de) Benzoylsubstituierte serin-amide
ATE482185T1 (de) Heteroaroylsubstituierte serin-amide
DE602006018447D1 (de) Substituierte indolverbindungen mit nos-hemmender aktivität
DE602007009238D1 (de) Biplanare elektrode mit sperr-gates
DE502005005266D1 (de) Dosierpumpe
DE602006018127D1 (de) Acetylenderivate
DE602005027905D1 (de) Nmr-rf-spulen mit verbessertem niederfrequenz-wirkungsgrad
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
ATE509925T1 (de) Substituierte bicyclocarbonsäureamidverbindungen
DK1989192T3 (da) 1,3-dioxane carboxylsyrer
ITFI20050094A1 (it) Opercolatrice perfezionata
DE602006001073D1 (de) Viehmarke
DE602006012689D1 (de) Überprüfungsverfahren
DE602005016309D1 (de) Laas-bodeneinrichtungs-sigma-monitor
ATE469643T1 (de) Mit gesättigten o-heterocyclen substituierte alkansäureamide
DE502006004614D1 (de) Fadenverbindungsvorrichtung
ATE488493T1 (de) Biphenyl- und naphthylphenylhydroxamsäurederivate
DE602006001668D1 (de) Fehlerüberprüfungsverfahren
FI20055334A (fi) Nelipyörä
ITMI20060151U1 (it) Moble
ES1060039Y (es) Mosquero perfeccionado
DE112006001556A5 (de) Schraube
ATE420094T1 (de) Substituierte propanphosphinsäureester

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1937248

Country of ref document: EP